Trial Profile
Compassionate Use of Ibalizumab for the Treatment of HIV Infection
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Jun 2017
Price :
$35
*
At a glance
- Drugs Ibalizumab (Primary) ; Dolutegravir
- Indications HIV infections
- Focus Expanded access; Therapeutic Use
- 31 Oct 2016 Status changed from recruiting to completed.
- 19 Jan 2014 New trial record